Drugs / WOKVAC Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03384914 Comparator | Feb 2018 → Dec 2025 overdue | HER2 positive breast carcinoma, female breast carcinoma, male breast carcinoma | H. Lee Moffitt Cancer Center and Research Institute | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WOKVAC Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03384914 ↗ |
| Route | Other | “via intradermal injection” NCT03384914 ↗ |